Phibro Animal Health (PAHC) Declares $0.12 Quarterly Dividend; 2.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health (PAHC) Tops Q1 EPS by 7c, Revenues Beat; Offers 2Q Revenue Guidance Below Consensus, 2Q EPS Mid-Point Guidance Below Consensus
February 3, 2021 4:48 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $206 million versus the consensus estimate of $205.48 million.
Highlights for the December 31, 2020 quarter (compared to the quarter ended December 31, 2019)
Net sales of $206 million, a decrease of $8 million, or 4%Net income of $13 million, an increase of $1 million, or 8%Diluted EPS of $0.32, an increase of $0.03, or 10%.Adjusted EBITDA of $29... More


